For those asking about long-term use: as a healthcare professional, I can say that for many with T2D, GLP-1s are a long-term management solution, much like other medications for chronic conditions. It's about managing health, not just a quick fix.
That's a great point. Significant weight loss can sometimes lead to a loss of muscle mass, so incorporating strength training is often recommended to maintain or rebuild muscle.
To answer MDW-to-ATL's question, it really depends on the patient's medical history and insurance coverage. Some people get it through their primary care physician, others through specialists. It's often covered for diabetes; weight loss coverage varies. Pre-authorization may be needed.
I'm really pleased with my results so far, and I sympathize with your insurance issues. I've been taking it for about a year now, and I still have quite a journey ahead of me, but I've managed to lose about 110 pounds.
SLU-PP-332 is interesting because it appears to be a triple agonist, affecting GLP-1, GIP, and glucagon receptors. It's distinct from the dual agonists we often discuss. More research is definitely needed to fully understand its potential benefits and risks.